BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29845011)

  • 1. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
    Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
    Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.
    Pavese N; Metta V; Bose SK; Chaudhuri KR; Brooks DJ
    Brain; 2010 Nov; 133(11):3434-43. PubMed ID: 20884645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic mediated body mass index changes in Parkinson's disease.
    Politis M; Loane C; Wu K; Brooks DJ; Piccini P
    Neurobiol Dis; 2011 Sep; 43(3):609-15. PubMed ID: 21624463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
    Qamhawi Z; Towey D; Shah B; Pagano G; Seibyl J; Marek K; Borghammer P; Brooks DJ; Pavese N
    Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.
    Roussakis AA; Politis M; Towey D; Piccini P
    Neurology; 2016 Mar; 86(12):1152-8. PubMed ID: 26920358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [
    Smit M; Vállez García D; de Jong BM; Zoons E; Booij J; Dierckx RA; Willemsen AT; de Vries EF; Bartels AL; Tijssen MA
    Front Neurol; 2018; 9():88. PubMed ID: 29541052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
    Pavese N; Simpson BS; Metta V; Ramlackhansingh A; Chaudhuri KR; Brooks DJ
    Neuroimage; 2012 Jan; 59(2):1080-4. PubMed ID: 21963917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Guttman M; Boileau I; Warsh J; Saint-Cyr JA; Ginovart N; McCluskey T; Houle S; Wilson A; Mundo E; Rusjan P; Meyer J; Kish SJ
    Eur J Neurol; 2007 May; 14(5):523-8. PubMed ID: 17437611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low thalamic monoamine transporter availability is related to excessive daytime sleepiness in early Parkinson's disease.
    Yoo SW; Oh YS; Ryu DW; Lee KS; Lyoo CH; Kim JS
    Neurol Sci; 2020 May; 41(5):1081-1087. PubMed ID: 31872354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease.
    Chou KL; Dayalu P; Koeppe RA; Gilman S; Spears CC; Albin RL; Kotagal V
    Mov Disord; 2022 Nov; 37(11):2301-2307. PubMed ID: 36102173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
    Boileau I; Warsh JJ; Guttman M; Saint-Cyr JA; McCluskey T; Rusjan P; Houle S; Wilson AA; Meyer JH; Kish SJ
    Mov Disord; 2008 Sep; 23(12):1776-80. PubMed ID: 18661545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
    Smith R; Wu K; Hart T; Loane C; Brooks DJ; Björklund A; Odin P; Piccini P; Politis M
    Neurobiol Aging; 2015 Apr; 36(4):1736-1742. PubMed ID: 25649022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD.
    Loane C; Wu K; Bain P; Brooks DJ; Piccini P; Politis M
    Neurology; 2013 May; 80(20):1850-5. PubMed ID: 23596065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of serotonergic Parkinson's disease-related covariance pattern using [
    Fu JF; Klyuzhin I; Liu S; Shahinfard E; Vafai N; McKenzie J; Neilson N; Mabrouk R; Sacheli MA; Wile D; McKeown MJ; Stoessl AJ; Sossi V
    Neuroimage Clin; 2018; 19():652-660. PubMed ID: 29946508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging of the Serotonergic System in Parkinson's Disease.
    Pagano G; Politis M
    Int Rev Neurobiol; 2018; 141():173-210. PubMed ID: 30314596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.